Stage IV Uveal Melanoma AJCC v7
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB05996 | Glembatumumab vedotin | 1 / 2 | Withdrawn | 1 |
DB06186 | Ipilimumab | 1 / 2 | Withdrawn | 1 |
DB09035 | Nivolumab | 1 / 2 | Withdrawn | 1 |
DB00062 | Albumin human | 2 | Completed | 1 |
DB00112 | Bevacizumab | 2 | Completed | 1 |
DB08875 | Cabozantinib | 2 | Completed | 1 |
DB00851 | Dacarbazine | 2 | Completed | 1 |
DB05996 | Glembatumumab vedotin | 2 | Completed | 1 |
DB03366 | Imidazole | 2 | Completed | 1 |
DB06186 | Ipilimumab | 2 | Active Not Recruiting | 2 |
DB06186 | Ipilimumab | 2 | Completed | 2 |
DB09035 | Nivolumab | 2 | Active Not Recruiting | 2 |
DB09035 | Nivolumab | 2 | Completed | 1 |
DB01229 | Paclitaxel | 2 | Completed | 1 |
DB14851 | Relatlimab | 2 | Completed | 1 |
DB00853 | Temozolomide | 2 | Completed | 1 |
DB08911 | Trametinib | 2 | Completed | 1 |
DB11969 | Uprosertib | 2 | Completed | 1 |
DB02546 | Vorinostat | 2 | Active Not Recruiting | 1 |
DB00020 | Sargramostim | 3 | Completed | 1 |
DB16626 | Tyrosinase | 3 | Completed | 1 |